HOME >> BIOLOGY >> NEWS
Leukemia drug turns mini-molecules up, cancer genes down

COLUMBUS , Ohio New research shows that a form of vitamin A used to treat acute promyelocytic leukemia induces changes in an unusual class of small molecules called microRNAs (miRNAs) in the leukemic cells.

The study also shows that three of these miRNAs inhibit the action of two genes important for cancer development, helping to explain how the drug works.

The drug is called all-trans-retinoic acid (ATRA) and it is considered the gold standard for treating the disease.

The study showed that ATRA raises the levels of three particular miRNAs in leukemia cells and that this rise coincides with a fall in activity of two important cancer-causing genes. The three are identified as miRNA-15b, miRNA-16-1 and let-7.

Two of these, miRNA-15b and miRNA-16-1, reduce the activity of the Bcl-2 gene, which is over-active in many kinds of cancer. The protein produced by this gene blocks the normal process of cell death and helps keep cancer cells alive long after they should have died.

The remaining miRNA molecule, let-7, lowered the activity of the Ras oncogene, an important cancer-causing gene. (Oncogenes are normal genes that when mutated lead to cancer.)

Researchers at the Ohio State University Comprehensive Cancer Center led the study, which was published in a recent issue of the journal Oncogene.

"The findings are important because they tell us that some miRNAs switch off genes that promote cancer," says first author Ramiro Garzon, a hematologist and oncologist at Ohio State's James Cancer Hospital and Solove Research Institute.

Acute promyelocytic leukemia occurs when cells that give rise to a form of white blood cell become stuck at an immature stage. The immature cells accumulate until they crowd out healthy white cells in the blood and bone marrow.

"Our findings suggest that these three miRNAs help re-program the malignant cells to a more normal state," Garzon says, "and that they a
'"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University
1-Mar-2007


Page: 1 2

Related biology news :

1. Loosen up, DNA: Leukemia gene changes genetic packaging
2. New treatment option breaks Leukemias resistance to chemotherapy, radiation therapy
3. VCU Massey Cancer Center researchers find new agent inhibits Leukemia cell survival
4. Leukemia, infection tied to aging stem cells, Stanford researchers say
5. OHSU turns mouse into factory for human liver cells
6. Jefferson researchers uncover new way nature turns genes on and off
7. Vax and Pax: Taking turns to build an eye
8. UC Riverside researchers show how the brain turns on innate behavior
9. NIH turns to FSU for top research on learning disabilities
10. Research shows how visual stimulation turns up genes to shape the brain
11. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 09, 2019 , ... ... hM4Di ligands – exciting compounds for scientists studying GPCR and DREADD signalling. Hello ... and the National Institute of Neurological Disorders and Stroke, both institutes of the ...
(Date:2/27/2019)... ... 2019 , ... Fluxion Biosciences, a leading developer of precision solutions for life ... grant for further development of its ERASE-Seq liquid biopsy technology. The Phase I grant ... Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the potential to ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... precision medicine, the traditional line between engineering and medical science grows ever thinner. ... smarter, the medical device industry is making medical practice easier for doctors, more ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... in Israel and the Middle East region, and Swiss-based CDMO Lonza announced ... platform. The partnership will enable Sheba to vastly streamline its in-house cell ...
(Date:3/14/2019)... PRINCETON, N.J. (PRWEB) , ... March 14, 2019 , ... ... will create challenges for companies to keep up. Traditional Regulatory intelligence ... times and adapting technology to get global Regulatory teams right Insights faster and cheaper. ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... gold standard solution for preclinical research organizations. It is a low code, ... connected systems and facilities, innovative technology-driven automated data capture and seamless data ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
Breaking Biology Technology:
Cached News: